CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandler, L. A.
Right arrow Articles by Bourgeois, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandler, L. A.
Right arrow Articles by Bourgeois, S.

Cell Growth & Differentiation, Vol 2, Issue 8 379-384, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Posttranscriptional down-regulation of fibronectin in N-ras-transformed cells

LA Chandler and S Bourgeois
Regulatory Biology Laboratory, Salk Institute for Biological Studies, San Diego, California 92186-5800.

The basal level of fibronectin (FN) biosynthesis is greatly reduced in N-ras-transformed human fibrosarcoma HT1080 cells when compared with normal fibroblasts. The rate of FN biosynthesis can be significantly increased in HT1080 cells by the synthetic glucocorticoid dexamethasone, which has been shown to act by selectively stabilizing the FN message (D.C. Dean, R.F. Newby, and S. Bourgeois, J. Cell Biol., 106: 2159-2170, 1988). The present study demonstrates that the basal levels of FN biosynthesis and accumulated FN mRNA are also reduced in HT1080 cells when compared with nontumorigenic revertants of HT1080 cells in which the mutated N-ras allele is underrepresented. In contrast, the FN promoter is more active in HT1080 cells than in the revertant cells. These results indicate that the down-regulation of FN in HT1080 cells is linked to expression of the N-ras oncogene and that the effect is posttranscriptional. Therefore, the N-ras oncogene and glucocorticoids have opposite posttranscriptional effects on FN biosynthesis in HT1080 cells. However, this study demonstrates that the stimulatory effects of glucocorticoids are not mediated by a transcriptional repression of the N-ras gene.


This article has been cited by other articles:


Home page
J Biol ChemHome page
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-{beta}1, Fibronectin, and Plasminogen Activator Inhibitor-1
J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. Scita, N. Darwiche, E. Greenwald, M. Rosenberg, K. Politi, and L. M. De Luca
Retinoic Acid Down-regulation of Fibronectin and Retinoic Acid Receptor Proteins in NIH-3T3 Cells: BLOCK OF THIS RESPONSE BY ras TRANSFORMATION
J. Biol. Chem., March 15, 1996; 271(11): 6502 - 6508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.